Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

A total of 36 consecutive patients with AML in CR underwent reduced-intensity allogeneic hematopoietic SCT (RISCT) with fludarabine and melphalan conditioning. All patients were ineligible for myeloablative transplantation because of age or comorbidity. In total, 30 patients were in first CR and six...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Main Authors: Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320641/
https://ncbi.nlm.nih.gov/pubmed/21423123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.61
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares